Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Feb 22;117(3):648-650.
doi: 10.1093/cvr/cvaa242.

Hiding in plain sight: an encapsulated approach to cardiac cell therapy

Affiliations
Editorial

Hiding in plain sight: an encapsulated approach to cardiac cell therapy

Megan M Monsanto et al. Cardiovasc Res. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Subcutaneous implantation of a TheraCyte device (gray box, centre) supported by host vasculature allows various cell types to be implanted in recipient hosts allowing for long-term tissue survival as well as extended release of extracellular vesicles (Evs), cytokines and growth factors (circles on right). Injured tissue such as infarcted myocardium benefits from systemic delivery of secretome and paracrine factors (pink shaded regions).

Comment on

References

    1. Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F.. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res 2009;104:398–402. - PMC - PubMed
    1. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, Oakley RM, El Choo A, Lee CN, Pasterkamp G, de Kleijn DPV.. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 2008;1:129–137. - PubMed
    1. Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, Oakley RM, El Pasterkamp G, de Kleijn DPV, Lim SK.. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4:214–222. - PubMed
    1. Yáñez-Mó M, Siljander PRM, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NHH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Linē A, Lipps G, Llorente A, Lötvall J, Manček-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen EN, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O.. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015;4:1–60. - PMC - PubMed
    1. Kompa AR, Greening DW, Kong AM, McMillan PJ, Fang H, Saxena R, Wong RCB, Lees JG, Sivakumaran P, Newcomb AE, Tannous BA, Kos C, Mariana L, Loudovaris T, Hausenloy DJ, Lim SY.. Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction. Cardiovasc Res 2021;117:918–929. - PMC - PubMed